收藏切换
Determination of furmonertinib in non-small cell lung cancer patients plasma by LC-MS/MS
收藏切换
PDF
Min-yu CHENG1, 2, Li LI2, Qi SHEN2, Hong-yu YANG3
Chinese Journal of Clinical Pharmacology | 2025, 41(6) : 862 - 865
Less
收藏切换
Chinese Journal of Clinical Pharmacology | 2025, 41(6): 862-865
Research Method
Determination of furmonertinib in non-small cell lung cancer patients plasma by LC-MS/MS
Full
Min-yu CHENG1, 2, Li LI2, Qi SHEN2, Hong-yu YANG3
Affiliations
  • 1.School of Pharmacy, Zhejiang University, Hangzhou 310012, Zhejiang Province, China
  • 2.Depatment of Pharmacy, Zhejiang Hospital, Hangzhou 310013, Zhejiang Province, China
  • 3.Department of Clinical Pharmacy, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang Province, China
Published: 2025-03-28 doi: 10.13699/j.cnki.1001-6821.2025.06.021
Outline
收藏切换
Objective

To devolope a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the determination of furmonertinib in human plsama and apply this method to analyze the blood concentration of non-small cell lung cancer (NSCLC) patients after taking medicine.

Methods

Furmonertinib -d3 was employed as the internal standard. The analyte and internal standard were extracted from plasma by protein precipitation with acetonitrile and chromatographed on Agilent Poroshell 120 SB-C18(2.1 mm×100.0 mm, 3.5 μm); mobile phase consisted of acetonitrile-10 mmoL-1 ammonium acetate(both of containing 0.1% formic acid); the whole analytical time was 3 min. The quantitative analysis were ionized with an electrospray ionization (ESI) source and operated in positive ion, multiple reaction monitoring (MRM) mode, the specificity, linear range, precision and accuracy, extraction recovery rate, matrix effect, dilution validation, and stability were all investigated.

Results

The standard curves were demonstrated to be liner in the range of 0.50-100.00 μg·L-1 with y=3.95×10-2x-4.16×10-4 (r=0.995 4). The accuracy was 95.8%-107.3%. The coefficient of variation (CV) of inter-day (n=6) and intra-day (n=3) for four different concentration levels were less than 15%. The average recoveries and matrix effects were between 83.1%-88.2% and 94.6%-105.8%.

Conclusion

The established LC-MS/MS method for determining the concentration of vormetinib meets the requirements of biological sample analysis and can be used for the concentration determination of vormetinib in clinical practice.

furmonertinib  /  liquid chromatography-tandem mass spectrometry  /  plasma concentration
Min-yu CHENG, Li LI, Qi SHEN, Hong-yu YANG. Determination of furmonertinib in non-small cell lung cancer patients plasma by LC-MS/MS[J]. Chinese Journal of Clinical Pharmacology, 2025 , 41 (6) : 862 -865 . DOI: 10.13699/j.cnki.1001-6821.2025.06.021
Year 2025 volume 41 Issue 6
PDF
0
0
Cite this Article
BibTeX
Article Info
doi: 10.13699/j.cnki.1001-6821.2025.06.021
  • Receive Date:2024-10-24
  • Online Date:2026-08-04
  • Published:2025-03-28
Article Data
Affiliations
History
  • Received:2024-10-24
Funding
Affiliations
    1.School of Pharmacy, Zhejiang University, Hangzhou 310012, Zhejiang Province, China
    2.Depatment of Pharmacy, Zhejiang Hospital, Hangzhou 310013, Zhejiang Province, China
    3.Department of Clinical Pharmacy, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang Province, China
References
Share
https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/10.13699/j.cnki.1001-6821.2025.06.021
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT